AccuType® CP, Clopidogrel CYP2C19 Genotype

The AccuType® CP, Clopidogrel CYP2C19 Genotype test contains 1 test with 1 biomarker.

Clopidogrel (Plavix®) is metabolized by CYP2C19 to its active form. This assay detects loss-of-function variants in the CYP2C19 gene leading to reduced therapeutic response to Clopidogrel treatment.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: AccuType CP Clopidogrel CYP2C19 Genotype

Accutype(R) Cp,

*Process times are an estimate and are not guaranteed. The lab may need additional time due to weather, holidays, confirmation/repeat testing, or equipment maintenance.